Bioterrorism: Are We Ready?
Malecki, Jean Marie, Clinical Psychiatry News
My experience with the nation's first anthrax case taught me that we must better prepare our medical systems to respond to bioterrorism. Only through extensive training can we become prepared.
Most communities are ill prepared to handle a bioterrorism event. A recent Rand Corp. survey found that fewer than half of all U.S. hospitals and local health departments have a formal bioterrorism response plan in place. Worse, fewer than 40% of those that do have ever tested their plans.
Until local health departments develop and test their own response plans, effective response is not going to happen. Plans mean nothing unless you test them.
The anthrax letters of October 2001 demonstrated the extent to which biological agents used by a terrorist can produce fear and panic in communities. Not just in Boca Raton, Fla., where the first anthrax case occurred with the untimely death of Robert Stevens on Oct. 5, 2001, but throughout the country. It also showed that we must rebuild the functions of public health as it relates to surveillance, detection, diagnosis, response, and recovery.
In fall 2001, there were 22 cases of anthrax in the United States. Five people died. Media coverage was continuous and often inaccurate. Mail delivery was disrupted in New Jersey, New York, and Washington, D.C. Anxiety was brought to nearly every home in the nation via the U.S. Postal Service. Up to 40,000 people took an antibiotic until supplies of the drug ran out in some parts of the country. The government offered immunizations to postal workers, but only 5% accepted.
The public health system didn't react much better. Hospitals, physicians, and health departments were besieged with inquiries about what people and organizations should do about these events, but were very poorly prepared to answer. …